CARROLL JILL purchased 14.6% of their position (277.78K shares) of AVALYN PHARMA INC. on the open market
Open‑market purchase worth $5.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/1/2026ACC: 0001193125-26-201894
-34.54M
Net shares
Net seller
$5.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
2.19M acquired · 36.73M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+1.42M
Price / share
—
Trade value
—
% of position
New position
5/1/2026
0.00→1.42M
Common Stock
Indirect
Shares
+489.49K
Price / share
—
Trade value
—
% of position
34.5%
5/1/2026
1.42M→1.91M
Common Stock
Indirect
Shares
+277.78K
Price / share
$18.00
Trade value
$5M
% of position
14.6%
5/1/2026
1.91M→2.19M
Total
Net shares
+2.19M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/1/2026 | C · Conversion | +1.42M | — | — | New position | 0.00 | 1.42M |
| Common Stock Indirect | 5/1/2026 | C · Conversion | +489.49K | — | — | 34.5% | 1.42M | 1.91M |
| Common Stock Indirect | 5/1/2026 | P · Purchase | +277.78K | $18.00 | $5M | 14.6% | 1.91M | 2.19M |
| Total | +2.19M | $5M | ||||||
Derivative Transactions2
Series C-1 Convertible Preferred Stock
Indirect
Converts to
Common Stock
1.42M shares
Shares
−27.31M
Strike price
Held after
0.00
Exercisable
—
5/1/2026
Series D Convertible Preferred Stock
Indirect
Converts to
Common Stock
489.49K shares
Shares
−9.42M
Strike price
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C-1 Convertible Preferred Stock Indirect | Common Stock1.42M shares | 5/1/2026 | C · Conversion | −27.31M | — | 0.00 | |
| Series D Convertible Preferred Stock Indirect | Common Stock489.49K shares | 5/1/2026 | C · Conversion | −9.42M | — | 0.00 |